These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13721385)

  • 21. [The practice guideline 'Rheumatoid arthritis' (first revision) from the Dutch College of General Practitioners: a response from the perspective of rheumatology].
    Bijlsma JW; Jacobs JW
    Ned Tijdschr Geneeskd; 2004 Mar; 148(12):557-8. PubMed ID: 15074176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design and analysis of a randomized controlled trial testing the effects of clinical decision support on the management of rheumatoid arthritis.
    Fransen J; Twisk JW; Creemers MC; van Riel PL
    Arthritis Rheum; 2004 Feb; 51(1):124-7. PubMed ID: 14872465
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dead Sea and Tiberias as health resort areas for patients suffering from different types of arthritis].
    Sukenik S; Abu-Shakra M; Kudish S; Flusser D
    Harefuah; 2006 Feb; 145(2):117-22, 165. PubMed ID: 16509416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What have we learnt from early rheumatoid arthritis cohorts?
    Young A
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):3-12. PubMed ID: 19233041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Will arthritis gene therapy become a clinical reality?
    Evans CH; Ghivizzani SC; Robbins PD
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):344-5. PubMed ID: 16932715
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural characterization of rheumatoid arthritis by MRI: applications in clinical research and in clinical practice.
    Peterfy C
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):360-1. PubMed ID: 15758259
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rheumatoid arthritis in adult: beginning the management in 3 months].
    Lioté F
    Rev Prat; 2005 Dec; 55(19):2103-5. PubMed ID: 16544920
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent developments in molecular therapeutic approaches for rheumatoid arthritis.
    Woods A; Hobson P; Klavinskis LS
    Curr Opin Mol Ther; 2004 Aug; 6(4):395-402. PubMed ID: 15468598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes of rheumatoid arthritis.
    Sokka T
    Curr Opin Rheumatol; 2009 May; 21(3):284-90. PubMed ID: 19342954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The measurement of outcome and the rheumatoid arthritis core set to lift the prejudice of the 'thaumaturgus cliche'.
    Bertinotti L; Nacci F; Matucci-Cerinic M
    Rheumatology (Oxford); 2006 Sep; 45(9):1055-7. PubMed ID: 16844702
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical aspects of rheumatoid arthritis].
    EDSTROM G
    Sven Lakartidn; 1958 May; 55(22):1616-28. PubMed ID: 13569254
    [No Abstract]   [Full Text] [Related]  

  • 32. Repeated measures in rheumatoid arthritis reduced the required sample size in a two-armed clinical trial.
    Mowinckel P; Hagen KB; Heiberg T; Kvien TK
    J Clin Epidemiol; 2008 Sep; 61(9):940-4. PubMed ID: 18538992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of trypsin in rheumatoid arthritis: a clinical study.
    GOODSON WH; ROSE DL; ALYEA WS
    J Kans Med Soc; 1954 Mar; 55(3):129-30. PubMed ID: 13163528
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the use of ascorbic acid in rheumatoid arthritis].
    DECOURT L; FERNANDES JM; LIMA MC; CHIORBOLI E
    Rev Paul Med; 1954 Apr; 44(4):281-5. PubMed ID: 13186434
    [No Abstract]   [Full Text] [Related]  

  • 35. The BeSt story: on strategy trials in rheumatoid arthritis.
    Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
    Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chloroquine-2,5-dihydroxybenzoate, new therapeutic agent for rheumatoid arthritis. II. Clinical study].
    SEJOURNET G
    Therapie; 1960; 15():887-91. PubMed ID: 13749831
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessing the safety of biologic therapies in rheumatoid arthritis: the challenges of study design.
    Hyrich KL
    J Rheumatol Suppl; 2005 Jan; 72():48-50. PubMed ID: 15660468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lysergic acid diethylamide. A clinical and psychological study].
    BRATTEMO CE; LASSENIUS B
    Nord Med; 1963 Feb; 69():193-7. PubMed ID: 14015013
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical effects of methylglucamine pyrocatecholcarboxylate injections].
    VAN HOORDE A
    Belg Tijdschr Geneesk; 1957 Feb; 13(4):191-7. PubMed ID: 13403854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.